Prelude Therapeutics
PRLD
#9184
Rank
HK$0.55 B
Marketcap
HK$10.10
Share price
46.40%
Change (1 day)
-69.28%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -HK$17.00

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$16.86. In 2022 the company made an earnings per share (EPS) of -HK$18.96 a decrease over its 2021 EPS that were of -HK$18.80.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$17.00-10.35%
2022-HK$18.960.83%
2021-HK$18.80-61.3%
2020-HK$48.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.94 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA